News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hoosier Oncology Group Selects OnCore to Support Clinical Trials Network



8/8/2013 9:13:26 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MADISON, Wis. and INDIANAPOLIS, Aug. 7, 2013 /PRNewswire/ -- Forte Research Systems, developer of specialized clinical research software, and the Hoosier Oncology Group ("the HOG"), a leading not-for-profit company specializing in the management of investigator-initiated clinical trials, are pleased to announce that HOG has selected Forte's OnCore® Enterprise Research system to support the trials of the newly formed Big Ten Cancer Research Consortium, as well as the HOG's additional portfolio of clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

The HOG will use functionality within OnCore to streamline the administration of trials, including financials management and electronic data capture, across its network.

Collaboration in Oncology Clinical Trials
The HOG supports more than 400 research center physicians and practitioners throughout its network. It is also the administrative headquarters of the Big Ten Cancer Research Consortium, a network consisting of 12 academic cancer centers and research universities that have come together to collaborate and conduct highly translational oncology trials.

Officially launched in June, the new consortium leverages its members' collective expertise and streamlines the process of conducting trials. Through their combined efforts, the centers have access to more than 30,000 new patients each year.

"The Big Ten Cancer Research Consortium is a new collaborative endeavor that has been created to transform the way oncology trials are conducted," said Tim Breen, Data Systems Director at the HOG. "It was important to select the right system to accomplish these goals, and we decided that the OnCore system was the best solution."

Srini Kalluri, Founder, CEO, and Chief Customer Officer at Forte, believes the selection of OnCore to support the consortium represents an opportunity to enhance existing relationships with institutions while building new ones. "We are pleased to have already been working with more than half of the institutions in the Big Ten Cancer Research Consortium, and we are excited to expand our support to the other institutions involved," he said. "The collaboration is an exciting new endeavor in clinical research, and we are thrilled to be a part of it."

About Forte Research Systems, Inc.
Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops and markets clinical and translational research software for better research compliance, patient safety, operational efficiency, and financial viability. The company's flagship product, the OnCore® Enterprise Research solution, has been meeting the needs of academic medical centers, CTSAs, research hospitals, and cancer centers for over a dozen years. Now, its proven electronic data capture platform is available as a stand-alone hosted solution for academic researchers, Overture EDC. For Research Sites, Site Networks, and SMOs, Forte offers Allegro® CTMS. Forte is also host to the Clinical Research Blog and other resources for individuals interested in excellence in clinical research operations.

About Hoosier Oncology Group
The Hoosier Oncology Group, Inc. (affectionately nicknamed "the HOG") consists of a working association of over 400 dedicated community and research center physicians and clinical research practitioners. The HOG is committed to improving therapy for cancer patients through clinical research throughout its network.

SOURCE Forte Research Systems, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES